In Markets

US’s Juul enters China

JUUL

US e-cigarettes maker Juul Labs Inc., which faces a widening crackdown on vaping at home, has entered China, with online storefronts on e-commerce sites owned by Alibaba Group and JD.com to tap the world’s largest market of smokers.

SEE ALSO : Pernod Ricard builds whisky distillery in China

Juul, in which tobacco giant Altria Group owns a 35 percent stake, has been launching its products in international markets such as South Korea, Indonesia, and Philippines. It recently raised over $750 million in an expanded funding round.

The U.S. government announced plans  to remove all flavored e-cigarettes from store shelves, as officials warned that sweet flavors had drawn millions of children into nicotine addiction.

The move comes as U.S. health officials are investigating a handful of deaths and potentially hundreds of lung illnesses tied to vaping.

A notice published on Juul’s official virtual store on Tmall, an Alibaba e-commerce site, said it had opened on Sept. 9. Juul also had a similar store on JD.com, another major Chinese online retailer.

Juul, Tmall, and JD.com did not immediately respond to requests for comment.

China, which is the world’s largest single market for tobacco consumption with over 300 million smokers, represents a market with both opportunity and risk for the company.

It is already home to dozens of Chinese competitors with names such as Relx, Yooz, and SNOW+ that have taken tens of millions of dollars in venture capital funding from high-profile investors.

SEE ALSO : Alibaba acquires NetEase’s Kaola

Like Juul, the competitors have adopted the concept of producing discrete devices that vaporize potent nicotine salts. China’s government has perennially launched anti-smoking campaigns in an effort to improve public health. Earlier this year it released a draft document suggesting that China’s laws regulating e-cigarettes will eventually largely resemble those in Europe.

(Source: Japan News)

Follow Retail in Asia on Facebook, Twitter and LinkedIn.

Get our top stories delivered to your inbox:

 

Stay ahead
Subscribe for free!
Register now
Stay ahead